vs
Side-by-side financial comparison of FONAR CORP (FONR) and Primis Financial Corp. (FRST). Click either name above to swap in a different company.
Primis Financial Corp. is the larger business by last-quarter revenue ($45.6M vs $25.5M, roughly 1.8× FONAR CORP). Primis Financial Corp. runs the higher net margin — 16.0% vs 8.0%, a 8.0% gap on every dollar of revenue. Over the past eight quarters, Primis Financial Corp.'s revenue compounded faster (13.0% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.
FONR vs FRST — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $45.6M |
| Net Profit | $2.1M | $7.3M |
| Gross Margin | — | — |
| Operating Margin | 13.5% | — |
| Net Margin | 8.0% | 16.0% |
| Revenue YoY | 2.4% | — |
| Net Profit YoY | 4.7% | 200.0% |
| EPS (diluted) | — | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $45.6M | ||
| Q4 25 | $25.5M | $80.9M | ||
| Q3 25 | $26.0M | $41.0M | ||
| Q2 25 | $27.3M | $43.2M | ||
| Q1 25 | $27.2M | $58.7M | ||
| Q4 24 | $24.9M | $38.8M | ||
| Q3 24 | $25.0M | $37.3M | ||
| Q2 24 | $25.9M | $35.7M |
| Q1 26 | — | $7.3M | ||
| Q4 25 | $2.1M | $29.5M | ||
| Q3 25 | $2.3M | $6.8M | ||
| Q2 25 | $729.3K | $2.4M | ||
| Q1 25 | $2.5M | $22.6M | ||
| Q4 24 | $2.0M | $-26.2M | ||
| Q3 24 | $3.1M | $1.2M | ||
| Q2 24 | $830.4K | $3.4M |
| Q1 26 | — | — | ||
| Q4 25 | 13.5% | 44.8% | ||
| Q3 25 | 14.1% | 21.3% | ||
| Q2 25 | 5.3% | 6.9% | ||
| Q1 25 | 15.2% | 41.9% | ||
| Q4 24 | 11.9% | -123.0% | ||
| Q3 24 | 21.0% | -3.1% | ||
| Q2 24 | 7.4% | 7.8% |
| Q1 26 | — | 16.0% | ||
| Q4 25 | 8.0% | 36.5% | ||
| Q3 25 | 8.7% | 16.7% | ||
| Q2 25 | 2.7% | 5.6% | ||
| Q1 25 | 9.2% | 38.6% | ||
| Q4 24 | 7.9% | -100.3% | ||
| Q3 24 | 12.6% | 3.3% | ||
| Q2 24 | 3.2% | 9.6% |
| Q1 26 | — | $0.30 | ||
| Q4 25 | — | $1.19 | ||
| Q3 25 | — | $0.28 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.92 | ||
| Q4 24 | — | $-0.95 | ||
| Q3 24 | — | $0.05 | ||
| Q2 24 | — | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | $159.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $176.9M | $427.2M |
| Total Assets | $217.2M | $4.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $159.9M | ||
| Q4 25 | $121.0K | $143.6M | ||
| Q3 25 | $122.0K | $63.9M | ||
| Q2 25 | $56.5M | $94.1M | ||
| Q1 25 | $123.0K | $57.0M | ||
| Q4 24 | $121.0K | $64.5M | ||
| Q3 24 | $136.0K | $77.3M | ||
| Q2 24 | $56.5M | $66.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.9K | — |
| Q1 26 | — | $427.2M | ||
| Q4 25 | $176.9M | $422.9M | ||
| Q3 25 | $174.9M | $382.2M | ||
| Q2 25 | $172.6M | $376.4M | ||
| Q1 25 | $171.9M | $375.6M | ||
| Q4 24 | $169.8M | $351.8M | ||
| Q3 24 | $168.7M | $381.0M | ||
| Q2 24 | $166.0M | $376.0M |
| Q1 26 | — | $4.3B | ||
| Q4 25 | $217.2M | $4.0B | ||
| Q3 25 | $218.4M | $4.0B | ||
| Q2 25 | $216.9M | $3.9B | ||
| Q1 25 | $214.9M | $3.7B | ||
| Q4 24 | $208.0M | $3.7B | ||
| Q3 24 | $212.3M | $4.0B | ||
| Q2 24 | $214.2M | $4.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | — |
| Free Cash FlowOCF − Capex | $-227.0K | — |
| FCF MarginFCF / Revenue | -0.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | 0.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $171.0K | $10.8M | ||
| Q3 25 | $1.7M | $-11.4M | ||
| Q2 25 | $4.2M | $-41.0M | ||
| Q1 25 | $3.1M | $34.4M | ||
| Q4 24 | $2.2M | $19.5M | ||
| Q3 24 | $1.7M | $6.1M | ||
| Q2 24 | $4.6M | $52.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-227.0K | $9.0M | ||
| Q3 25 | $-177.0K | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $1.5M | $18.3M | ||
| Q3 24 | $-148.0K | — | ||
| Q2 24 | $4.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.9% | 11.2% | ||
| Q3 25 | -0.7% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | 9.4% | — | ||
| Q4 24 | 6.0% | 47.3% | ||
| Q3 24 | -0.6% | — | ||
| Q2 24 | 16.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 2.1% | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 3.0% | 3.1% | ||
| Q3 24 | 7.2% | 0.0% | ||
| Q2 24 | 1.6% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | 0.36× | ||
| Q3 25 | 0.75× | -1.67× | ||
| Q2 25 | 5.79× | -16.82× | ||
| Q1 25 | 1.26× | 1.52× | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 0.53× | 4.93× | ||
| Q2 24 | 5.54× | 15.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
